Virginia Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History

Virginia Retirement System’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.45M	Buy	+21,641	New	+$1.32M	0.02%	453

Other funds holding LGND

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Virginia Retirement System's LGND Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2016: 21,641 shares worth $1.45M. The stake represents 0.02% of the portfolio and ranks #453 among its holdings.

251 funds tracked by Wall St. Rank hold LGND as of Q1 2016.

Virginia Retirement System held 21,641 shares of Ligand Pharmaceuticals worth $1.45M as of Q1 2016.
Ligand Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Ligand Pharmaceuticals made up 0.02% of Virginia Retirement System's portfolio in Q1 2016, its #453 holding.
251 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.